Stock Events

Mckesson 

$481.13
415
-$2.46-0.51% Friday 15:30

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
-
P/E Ratio
0.67
Dividend Yield
0.59%
Dividend
2.84

Upcoming

Dividends

0.59%Dividend Yield
10Y Growth
10.73%
5Y Growth
10.7%
3Y Growth
14.33%
1Y Growth
14.66%

Earnings

6NovExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
5.87
6.54
7.21
7.88
Expected EPS
7.36
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 0JZU.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMERISOURCEBERGEN CORP
ABC
Mkt Cap34.08B
AmerisourceBergen is a direct competitor, operating in the same pharmaceutical distribution and healthcare services sector as McKesson.
Cardinal Health
CAH
Mkt Cap27.49B
Cardinal Health is another major player in the pharmaceutical distribution industry, directly competing with McKesson in terms of product range and services.
Walgreens Boots Alliance
WBA
Mkt Cap7.99B
Walgreens Boots Alliance, through its wholesale division, competes in the pharmaceutical wholesaling and distribution market.
CVS Health
CVS
Mkt Cap72.01B
CVS Health operates in the healthcare and pharmaceuticals sector, competing with McKesson in pharmacy services and healthcare solutions.
Owens & Minor
OMI
Mkt Cap1.2B
Owens & Minor provides healthcare logistics services, competing with McKesson in the medical supplies distribution sector.
Henry Schein
HSIC
Mkt Cap8.94B
Henry Schein competes in the distribution of healthcare products and services, overlapping with McKesson's medical-surgical segment.
Patterson Companies
PDCO
Mkt Cap1.98B
Patterson Companies competes with McKesson in the distribution of dental and animal health products, areas where McKesson also operates.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap21.38B
Teva Pharmaceutical Industries, as a large generic pharmaceutical manufacturer, competes indirectly by supplying similar generic drugs as McKesson.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson, through its broad range of healthcare products, competes in various segments where McKesson is also present.

About

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Show more...
CEO
Mr. Brian S. Tyler Ph.D.
Employees
45000
Country
US
ISIN
US58155Q1031

Listings